RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Key facts

Sponsor

Radiation Therapy Oncology Group

Principal Investigator

Mitchell Machtay, MD, MD

Milton S. Hershey Medical Center, Penn State Health

Intervention

cetuximab(biological)

Enrollment

702 enrolled

Eligibility

18 years · All sexes

Timeline

2010 – 2029

Study locations (30)

• University of Alabama at Birmingham, Birmingham, Alabama, United States
• Arizona Oncology Associates-West Orange Grove, Tucson, Arizona, United States
• Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States
• Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States
• Mercy San Juan Medical Center, Carmichael, California, United States
• City of Hope, Duarte, California, United States
• UC San Diego Moores Cancer Center, La Jolla, California, United States
• Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
• Los Angeles County-USC Medical Center, Los Angeles, California, United States
• University of Southern California/Norris Cancer Center, Los Angeles, California, United States
• Memorial Medical Center, Modesto, California, United States
• Bay Area Tumor Institute CCOP, Oakland, California, United States
• Pomona Valley Hospital Medical Center, Pomona, California, United States
• Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, United States
• The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI) · NRG Oncology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07195734
  Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  National Cancer Institute (NCI)
• RECRUITINGNANCT07264036
  Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
  Vanessa Torrecillas
• RECRUITINGPHASE2NCT07121595
  Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
  University of Michigan Rogel Cancer Center
• RECRUITINGNCT05837221
  Microbiome in Head and Neck Squamous Cell Carcinoma
  University of Colorado, Denver
• RECRUITINGPHASE2NCT05576974
  A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
  University of Texas Southwestern Medical Center
• RECRUITINGPHASE1, PHASE2NCT06265025
  GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
  GeneMedicine Co., Ltd.
• RECRUITINGNANCT05811936
  The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
  Medical University of South Carolina
• ACTIVE NOT RECRUITINGPHASE1NCT05820711
  Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
  University of Wisconsin, Madison

See all trials for Squamous cell carcinoma of oral cavity and lip →